Press Releases

The Company’s Proposed Pharmaceutical Grade Version of Tauri-Gum™ is Being Developed for Nausea Regulation, Intended Specifically to Target: Patients Subjected to Ongoing Chemotherapy Treatment(s) (the “Indication”) NEW YORK, NY, June 05, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”),...

Read More

The Company has Established Relationships with Hundreds of Distinct NY Metro Area Retail Locations (i.e. Supermarkets, Delis, Kiosks, Specialty Grocers, Pharmacies, Smoke Shops, etc.) NEW YORK, NY, June 05, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue...

Read More

This Proposed Tauri-Gum™ Product Version (6th Tauri-Gum™ Version) Will Not Contain any Phytocannabinoids   Flavor: PEAR BELLINI -- (Comprised of All-Natural Pear & Champagne Grape Flavoring) NEW YORK, NY, June 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences...

Read More